Cutler Group LP Tg Therapeutics, Inc. Call Options Transaction History

Cutler Group LP

$307 Million
Q1 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 07, 2023	BUY	$8.36 - $26.5 $25,080 - $79,500	3,000 New	3,000 $0
Q4 2022 Feb 07, 2023	BUY	$5.01 - $11.83 $160,821 - $379,743	32,100 Added 32100.0%	32,200 $27,000
Q3 2022 Oct 25, 2022	SELL	$4.57 - $8.4 $10,054 - $18,480	-2,200 Reduced 95.65%	100 $0
Q2 2022 Aug 04, 2022	SELL	$3.74 - $10.66 $99,858 - $284,622	-26,700 Reduced 92.07%	2,300 $0
Q1 2022 Apr 14, 2022	BUY	$7.81 - $20.45 $76,538 - $200,410	9,800 Added 51.04%	29,000 $15,000
Q4 2021 Jan 18, 2022	SELL	$15.2 - $35.51 $142,880 - $333,794	-9,400 Reduced 32.87%	19,200 $36,000
Q3 2021 Oct 26, 2021	BUY	$21.78 - $40.45 $544,500 - $1.01 Million	25,000 Added 694.44%	28,600 $151,000
Q2 2021 Jul 19, 2021	BUY	$32.5 - $48.96 $84,500 - $127,296	2,600 Added 260.0%	3,600 $18,000
Q1 2021 Apr 26, 2021	SELL	$41.61 - $54.3 $79,059 - $103,170	-1,900 Reduced 65.52%	1,000 $20,000
Q4 2020 Jan 21, 2021	BUY	$25.27 - $54.9 $12,635 - $27,450	500 Added 20.83%	2,900 $39,000
Q3 2020 Oct 27, 2020	BUY	$18.49 - $27.24 $25,885 - $38,136	1,400 Added 140.0%	2,400 $13,000
Q2 2020 Jul 22, 2020	SELL	$8.9 - $21.84 $35,600 - $87,360	-4,000 Reduced 80.0%	1,000 $4,000
Q1 2019 May 10, 2019	SELL	$4.02 - $8.04 $13,667 - $27,335	-3,400 Reduced 40.48%	5,000 $10,000
Q4 2018 Feb 05, 2019	BUY	$3.44 - $5.76 $17,200 - $28,800	5,000 Added 147.06%	8,400 $4,000
Q3 2018 Nov 07, 2018	SELL	$5.15 - $14.0 $41,715 - $113,400	-8,100 Reduced 70.43%	3,400 $0
Q2 2018 Aug 10, 2018	BUY	$12.5 - $15.0 $6,250 - $7,500	500 Added 4.55%	11,500 $5,000
Q1 2018 May 11, 2018	SELL	$8.7 - $16.8 $49,589 - $95,760	-5,700 Reduced 34.13%	11,000 $14,000
Q4 2017 Jan 17, 2018	SELL	$7.35 - $12.3 $194,775 - $325,950	-26,500 Reduced 61.34%	16,700 $5,000
Q3 2017 Oct 17, 2017	BUY	$10.0 - $12.7 $432,000 - $548,640	43,200	43,200 $83,000

Others Institutions Holding TGTX

# of Institutions

336

Shares Held

87.6M

Call Options Held

2.35M

Put Options Held

1.7M

Vanguard Group Inc Valley Forge, PA

15.4M
Shares

$448 Million
0.01% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$332 Million
0.0% of portfolio
State Street Corp Boston, MA

9.09M
Shares

$265 Million
0.01% of portfolio
Pictet Asset Management Holding Sa Carouge, V8

3.58M
Shares

$104 Million
0.1% of portfolio
Geode Capital Management, LLC Boston, MA

3.21M
Shares

$93.4 Million
0.01% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.23B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Account